Nik Wallenda, first man to complete 1800-feet tightrope walk across Niagara Falls

June 16, 2012

niagara_falla_tightrope_walk.295

Ontario, Canada, June 16: Daredevil Nik Wallenda became the first person to walk on a tightrope across the Niagara Falls, taking steady, measured steps Friday night for 1,800 feet across the mist-fogged brink of the roaring falls separating the U.S. and Canada.

"I feel like I'm on cloud nine right now," an exuberant Wallenda told reporters after accomplishing what he said was his childhood dream before an estimated 112,000 people crowding the shores of both countries and millions more who watched a live television broadcast.

He described wind "coming from every which way," mist so powerful he had to blink it away to maintain his vision and a breathtaking view during the nighttime walk illuminated by spotlights that "compared to nothing."

"There was no way to focus on the movement of the cable," said Wallenda, 33. "If I looked down at the cable there was water moving everywhere. And if I looked up there was heavy mist blowing in front of my face. So it was a very unique, a weird sensation."

He said he accomplished the feat through "a lot of praying, that's for sure. But, you know, it's all about the concentration, the focus, and the training."

The seventh-generation member of the famed Flying Wallendas had long dreamed of pulling off the stunt, never before attempted. Other daredevils have wire-walked over the Niagara River but farther downstream and not since 1896.


"This is what dreams are made of, people," said Wallenda, who wore a microphone for the broadcast, shortly after he stepped off from a platform on the American shore.

Along the way, he calmly prayed aloud.

After passing the halfway mark, Wallenda expressed fatigue. "I'm strained, I'm drained," he said. "This is so physical, not only mental but physical."

Toward the end, as he neared the Canadian shore, Wallenda dropped to one knee and pumped his fist while the spectators cheered.


He broke into a playful run about 15 feet from the finish line, where his wife and three children waited.

"I am so blessed," he said later. "How blessed I am to have the life that I have."

ABC televised the walk and insisted Wallenda use a tether to keep him from falling in the river. Wallenda said he agreed because he wasn't willing to lose the chance to perform the walk it took him well over a year to win permission from two countries to do. Such stunts are normally illegal. ABC's sponsorship helped offset some of the $1.3 million cost of the spectacle.

Wallenda said he thought about the tether, which was secured at his waist and dragged behind him, at several points along the 30-minute walk but wasn't hindered by it as he'd feared.

"Awesome! The whole thing is awesome," 8-year-old William Clements of Dresden, Ontario, said after watching the walk with his family from the Canadian side, adding he wouldn't want to walk "even over something not high."

"He was meant to do it. The weather was perfect," said Glenda Rutherford of Ontario. "It was amazing."

For Wallenda, who has grown up on the high wire and holds six Guinness records for various stunts, the Niagara Falls walk was unlike anything he'd ever done. Because it was over water, the 2-inch wire didn't have the usual stabilizer cables to keep it from swinging. Pendulum anchors were designed to keep it from twisting under the elkskin-soled shoes designed by his mother.

The Wallendas trace their roots to 1780 Austria-Hungary, when ancestors traveled as a band of acrobats, aerialists, jugglers, animal trainers and trapeze artists. The clan has been touched by tragedy, notably in 1978 when patriarch Karl Wallenda, Nik's great-grandfather, fell to his death during a stunt in Puerto Rico.

Wallenda said that at one point in the middle of the walk, he thought about his great-grandfather and the walks he had taken:


"That's what this is all about, paying tribute to my ancestors, and my hero, Karl Wallenda."

About a dozen other tightrope artists have crossed the Niagara Gorge downstream, dating to Jean Francois Gravelet, aka The Great Blondin, in 1859. But no one had walked directly over the falls, and authorities hadn't allowed any tightrope acts in the area since 1896. It took Wallenda two years to persuade U.S. and Canadian authorities to allow it, and many civic leaders hoped to use the publicity to jumpstart the region's struggling economy, particularly on the U.S. side of the falls.




Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 24,2020

Jun 24: The coronavirus tally in Pakistan reached 188,926 with the detection of 3,892 new cases in the last 24 hours, the health ministry said on Wednesday.

Sixty more people died due to the viral infection, taking the death toll to 3,755.

As many as 3,337 patients are in critical condition across the country, the ministry said.

With the detection of 3,892 new cases in the last 24 hours, the coronavirus tally in the country now stands at 188,926, it said.

Sindh reported the maximum number of 72,656 cases, followed by 69,536 in Punjab, 23,388 in Khyber-Pakhtunkhwa, 11,483 in Islamabad, 9,634 in Balochistan, 1,337 in Gilgit-Baltistan and 892 in Pakistan-occupied Kashmir (Pok).

Health authorities have so far conducted 1,150,141 coronavirus tests, including 23,380 in the last 24 hours.

A total of 77,754 patients have recovered so far from the disease.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 4,2020

Madrid, Apr 4: Spain recorded a second successive daily drop in coronavirus-related deaths with 809 fatalities, official figures showed Saturday.

The total number of deaths in Spain now stands at 11,744, second only to Italy. A record 950 people died on Thursday.

The number of new cases also slowed at 7,026, taking the total to 124,736.

Recoveries over the last 24 hours stood at 3,706, taking that total to 34,219.

The Madrid region was the worst affected accounting for 40 percent of the deaths, 4,723, and 29 percent of the cases at 36,249. The northeastern region of Catalonia was in second place with 2,508 deaths.

Prime Minister Pedro Sanchez is due to decide whether to prolong the emergency measures and confinement declared on March 14 for another two weeks in order to get on top of the outbreak.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 4,2020

Jun 4: A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.

Results published Wednesday by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus.

The drug did not seem to cause serious harm, though -- about 40% on it had side effects, mostly mild stomach problems.

 “We were disappointed. We would have liked for this to work,” said the study leader, Dr. David Boulware, an infectious disease specialist at the University of Minnesota.

“But our objective was to answer the question and to conduct a high-quality study,” because the evidence on the drug so far has been inconclusive, he said.

Hydroxychloroquine and a similar drug, chloroquine, have been the subject of much debate since Trump started promoting them in March.

Hydroxychloroquine has long been used for malaria, lupus, and rheumatoid arthritis, but no large studies have shown it or chloroquine to be safe or effective for much sicker patients with coronavirus, and some studies have suggested the drugs may do harm.

Trump took a two-week course of hydroxychloroquine, along with zinc and Vitamin D, after two staffers tested positive for COVID-19, and had no ill effects, according to results of his latest physical released by his doctor Wednesday.

Federal regulators have warned against hydroxychloroquine's use except in hospitals and formal studies because of the risk of side effects, especially heart rhythm problems.

Boulware's study involved 821 people in the United States and Canada living with someone diagnosed with COVID-19 or at high risk of getting it because of their job -- doctors, nurses, ambulance workers who had significant exposure to a sick patient while not wearing full protective gear.

They were randomly assigned to get either the nutrient folate as a placebo or hydroxychloroquine for five days, starting within four days of their exposure. Neither they nor others involved in the research knew who was getting which pills.

After 14 days in the study, 12 per cent on the drug developed COVID-19 symptoms versus 14 per cent in the placebo group, but the difference is so small it could have occurred by chance, Boulware said.

“There's basically no effect. It does not prevent infection,” he said of the drug. Even if it were to give some slim advantage, “we'd want a much larger effect” to justify its use and risk of side effects for preventing illness, he said.

Results were no different among a subgroup of participants who were taking zinc or vitamin C, which some people believe might help make hydroxychloroquine more effective or fight the coronavirus.

There are some big caveats: The study enrolled people through the Internet and social media, relying on them to report their own symptoms rather than having them tracked in a formal way by doctors.

Participants were not all tested for the coronavirus but were diagnosed as COVID-19 cases based on symptoms in many cases. And not all took their medicines as directed.

The results “are more provocative than definitive,” and the drug may yet have prevention benefits if tried sooner or in a different way, Dr. Myron Cohen of the University of North Carolina at Chapel Hill wrote in a commentary in the journal.

Others were glad to see a study that had a comparison group and good scientific methods after so many weaker reports on hydroxychloroquine.

“This fits with everything else we've seen so far which suggests that it's not beneficial," said Dr. Peter Bach, director of a health policy center at Memorial Sloan Kettering Cancer Center in New York.

This study was in younger relatively healthy people, but the results “would make me very discouraged about trying to use this in older people” who are most vulnerable to serious illness from the coronavirus, Bach said.

“If it does work, it doesn't work very well.” Dr. Dan Culver, a lung specialist at the Cleveland Clinic, said there's still a chance that giving the drug sooner than four days after someone's exposure to the virus may help prevent illness.

But the study “takes 'home run' off the table” as far as hopes for the drug, he said.

The study was mostly funded by David Baszucki, founder of Roblox, a California-based game software company, and other private donors and the Minnesota university.

Boulware also is leading a study testing hydroxychloroquine for treating COVID-19. The study is finished and results are being analyzed now.

On Tuesday, the journal Lancet posted an “expression of concern” about a study it published earlier this month of nearly 15,000 COVID-19 patients on the malaria drugs that tied their use to a higher risk of dying in the hospital or developing a heartbeat problem.

Scientists have raised serious questions about the database used for that study, and its authors have launched an independent audit.

That work had a big impact: the World Health Organization suspended use of hydroxychloroquine in a study it is leading, and French officials stopped the drug's use in hospitals. On Wednesday, the WHO said experts who reviewed safety information decided that its study could resume.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.